Ablation should be 1st line therapy in the high risk Brugada Syndrome patient - PRO
20 March 2018 (08:34 - 08:47)
Organised by:
Slides
About the speaker
University Hospital of Nantes, Nantes (France)
11 More presentations in this session
Professor S. Viskin (Tel Aviv, IL)
Access the full session
The Event
EHRA 2018
20 March 2018
08:34 CET
